Showing results (1291-1300 of 1,518) with videos related to

Sort By:
Pageof 152
Military Medicine|September 23, 2025
The Veteran Military Occupational and Environmental Exposure Assessment Tool, Phase III EnhancementsCalvin Lu, Patricia Stewart, Charity Breneman, et al.
The Journal of Dermatological Treatment|July 25, 2025
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitisJenny E Murase, Kilian Eyerich, Raj Chovatiya, et al.
Nature Communications|November 11, 2023
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trialSun Min Lim, Solange Peters, Ana Laura Ortega Granados, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)Michael Kreuter, Johan Vansteenkiste, Jürgen R Fischer, et al.
Cancer Research|May 20, 2016
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and InvasionSebastian Marwitz, Sofia Depner, Dmytro Dvornikov, et al.
Parasitology Research|February 20, 2019
Detection of Rangelia vitalii (Piroplasmida: Babesiidae) in asymptomatic free-ranging wild canids from the Pampa biome, BrazilViviane Kelin de Souza, Bruno Dall'Agnol, Ugo Araújo Souza, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 21, 2016
Patch Testing for Evaluation of Hypersensitivity to Implanted Metal Devices: A Perspective From the American Contact Dermatitis SocietyPeter C Schalock, Glen Crawford, Susan Nedorost, et al.
International Journal of Cancer|March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)Fabian Acker, Katharina Wenger, Martin Reck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 StudyJhanelle E Gray, Joel W Neal, Jyoti D Patel, et al.
JTO Clinical and Research Reports|June 3, 2025
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLC: RELAY Japanese SubsetMakoto Nishio, Takashi Seto, Martin Reck, et al.
Pageof 152